WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Raccontata dabiopharmadive.comlavanguardia.comendpoints.news

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
biopharmadive.comStai leggendo1 g fa

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

originale
endpoints.news1 g fa

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.

Leggi questa versione → originale
lavanguardia.com1 g fa

Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

La compañía destinará buena parte de los recursos a los ensayos clínicos de su molécula estrella

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 4 giugno 2026·biopharmadive.com

    A Spanish biotech banks $87M to make differentiated ADCs

    Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

  2. giovedì 4 giugno 2026·lavanguardia.com

    Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

    La compañía destinará buena parte de los recursos a los ensayos clínicos de su molécula estrella

  3. giovedì 4 giugno 2026·endpoints.news

    ADC biotech Ona Therapeutics secures $86.6M in Series B raise

    Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.